Search | Clinical Trials Finder

These results were retrieved from the live ClinicalTrials.gov registry. Filters and sort order apply to this result list.

ClinicalTrials.gov public records Last synced Nov 7, 2026, 2:02 AM EST

All trial information on this site comes from the official ClinicalTrials.gov public API (clinicaltrials.gov/api/v2), run by the U.S. National Library of Medicine. We only display that public information; we do not add opinions, endorsements, or any other intent. Always review the official ClinicalTrials.gov record for the latest information.

Showing 1921–1944 of 2,293 matching trials from the live ClinicalTrials.gov search.

Filters: Condition: Cardiac Ischemia Clear all

Conditions: Cardiogenic Shock, Acute; Myocardial Infarction, Complications
Interventions: data collection of clinically available procedures; Other
Lead sponsor: Wake Forest University Health Sciences; Other
Eligibility: 18 Years and older
Enrollment: 120 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2019 – 2022
U.S. locations: 1
States / cities: Charlotte, North Carolina

Conditions: High-risk Percutaneous Coronary Intervention, Heart Disease, Coronary
Interventions: VITALYST System; Device
Lead sponsor: Boston Scientific Corporation; Industry
Eligibility: 18 Years to 89 Years
Enrollment: 15 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2024 – 2025
U.S. locations: 4
States / cities: Atlanta, Georgia • Boston, Massachusetts • New York, New York

Conditions: Atherosclerosis
Interventions: Aliskiren, Placebo; Drug
Lead sponsor: Ohio State University; Other
Eligibility: 45 Years and older
Enrollment: 71 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2009 – 2012
U.S. locations: 1
States / cities: Columbus, Ohio

Conditions: Coronary Artery Disease
Interventions: Not listed
Lead sponsor: Cardiopulmonary Research Science and Technology Institute; Other
Eligibility: 18 Years and older
Enrollment: 100 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2010 – 2014
U.S. locations: 2
States / cities: Dallas, Texas • Plano, Texas

Conditions: Diabetes Mellitus, Type 2, Acute Coronary Syndrome
Interventions: Alogliptin, Placebo; Drug
Lead sponsor: Takeda; Industry
Eligibility: 18 Years and older
Enrollment: 5,380 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2009 – 2013
U.S. locations: 292
States / cities: Birmingham, Alabama • Dothan, Alabama • Mobile, Alabama + 289 more

Conditions: Microvascular Angina, Angina Pectoris
Interventions: Quality of Life assessment, Stress imaging; Other · Procedure
Lead sponsor: NYU Langone Health; Other
Eligibility: 21 Years to 100 Years
Enrollment: 212 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2014 – 2019
U.S. locations: 1
States / cities: New York, New York

Conditions: Myocardial Infarction
Interventions: ED Activation/Immediate Transfer; Other
Lead sponsor: St. Francis Hospitals & Health Centers; Other
Eligibility: 18 Years and older
Enrollment: 1,000 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2005 – 2012
U.S. locations: 1
States / cities: Indianapolis, Indiana

Conditions: Coronary Artery Disease
Interventions: Atorvastatin; Drug
Lead sponsor: Indiana University; Other
Eligibility: 21 Years to 85 Years
Enrollment: 60 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2008 – 2014
U.S. locations: 2
States / cities: Indianapolis, Indiana

Conditions: Myocardial Infarction, Coronary Artery Disease
Interventions: Full drug coverage, Usual coverage; Other
Lead sponsor: Brigham and Women's Hospital; Other
Eligibility: 18 Years to 65 Years
Enrollment: 5,860 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2007 – 2010
U.S. locations: 1
States / cities: Hartford, Connecticut

Conditions: Coronary Artery Disease
Interventions: Immediate disclosure of CAD PRS results, Deferred Disclosure of CAD PRS results; Behavioral
Lead sponsor: Massachusetts General Hospital; Other
Eligibility: 30 Years to 75 Years
Enrollment: 500 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2025 – 2027
U.S. locations: 1
States / cities: Boston, Massachusetts

Conditions: Atrial Fibrillation, Stroke
Interventions: WATCHMAN Left Atrial Appendage Closure Technology, Warfarin; Device · Drug
Lead sponsor: Boston Scientific Corporation; Industry
Eligibility: 18 Years and older
Enrollment: 800 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2005 – 2014
U.S. locations: 58
States / cities: Gilbert, Arizona • Scottsdale, Arizona • La Jolla, California + 46 more

Conditions: Diabetes, Hypertension, High Cholesterol/Hyperlipidemia, Coronary Artery Disease, Congestive Heart Failure, Chronic Lung Disease, Chronic Kidney Diseases, Arrythmia, Stroke, Depression, Anxiety, Pulmonary Embolism, Heart Attack
Interventions: Med AAAction intervention; Other
Lead sponsor: University of Tennessee; Other
Eligibility: 18 Years and older
Enrollment: 388 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2024 – 2028
U.S. locations: 2
States / cities: Knoxville, Tennessee • Memphis, Tennessee

Conditions: Coronary Occlusions
Interventions: Cypher sirolimus eluting coronary stent; Device
Lead sponsor: Sunil Rao; Other
Eligibility: 18 Years and older
Enrollment: 200 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2005 – 2012
U.S. locations: 13
States / cities: La Jolla, California • Washington D.C., District of Columbia • Atlanta, Georgia + 8 more

Conditions: Chest Pain, Acute Coronary Syndrome, Acute Myocardial Infarction, Coronary Artery Disease
Interventions: CT Coronary Angiography (CTCA), Traditional Strategy; Diagnostic Test · Procedure
Lead sponsor: American College of Radiology; Other
Eligibility: 30 Years and older
Enrollment: 1,392 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2009 – 2012
U.S. locations: 5
States / cities: Winston-Salem, North Carolina • Hershey, Pennsylvania • Philadelphia, Pennsylvania + 1 more

Conditions: Cardiomyopathy
Interventions: Ranolazine; Drug
Lead sponsor: Cardiovascular Institute of the South Clinical Research Corporation; Other
Eligibility: 18 Years to 80 Years
Enrollment: 14 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2012 – 2017
U.S. locations: 1
States / cities: Lafayette, Louisiana

Conditions: Down Syndrome, Autonomic Dysfunction
Interventions: Cold Stress, Maximal Dynamic Exercise, Isometric Handgrip Exercise with Post-Exercise Muscle Ischemia, Head-up Tilt Table Test; Other
Lead sponsor: University of Colorado, Denver; Other
Eligibility: 18 Years to 50 Years
Enrollment: 200 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2026 – 2030
U.S. locations: 1
States / cities: Aurora, Colorado

Conditions: Angina Pectoris
Interventions: pVGI.1(VEGF2); Genetic
Lead sponsor: Corautus Genetics; Industry
Eligibility: 18 Years and older
Enrollment: 404 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: Started 2004
U.S. locations: 35
States / cities: Birmingham, Alabama • Phoenix, Arizona • La Jolla, California + 27 more

Conditions: Coronary Artery Disease, Acute Myocardial Infarction
Interventions: Enoxaparin; Drug
Lead sponsor: Corewell Health East; Other
Eligibility: 18 Years to 80 Years
Enrollment: 60 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2000 – 2004
U.S. locations: 6
States / cities: Denver, Colorado • Royal Oak, Michigan • Syracuse, New York + 3 more

Conditions: Foramen Ovale, Patent, Stroke, Ischemic
Interventions: NobleStitch™EL Suture Mediated Closure System, Amplatzer PFO Occluder; Device
Lead sponsor: Nobles Medical Technologies II Inc; Industry
Eligibility: 18 Years to 60 Years
Enrollment: 640 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2021 – 2027
U.S. locations: 1
States / cities: Tucson, Arizona

Conditions: Cardiac Arrest Due to Underlying Cardiac Condition, Ventricular Fibrillation, Cardiopulmonary Arrest With Successful Resuscitation
Interventions: Initial CCL admission, Initial ICU admission; Procedure · Diagnostic Test
Lead sponsor: University of Minnesota; Other
Eligibility: 18 Years to 75 Years
Enrollment: 65 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2017 – 2019
U.S. locations: 21
States / cities: Atlanta, Georgia • Indianapolis, Indiana • Ann Arbor, Michigan + 14 more

Conditions: Acute Coronary Syndrome (ACS), Myocardial Infarction
Interventions: Not listed
Lead sponsor: Ortho-Clinical Diagnostics, Inc.; Industry
Eligibility: 22 Years and older
Enrollment: 1,630 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2018 – 2021
U.S. locations: 24
States / cities: Montgomery, Alabama • Chandler, Arizona • New Haven, Connecticut + 20 more

Conditions: Coronary Disease
Interventions: BVS implantation; Device
Lead sponsor: Icahn School of Medicine at Mount Sinai; Other
Eligibility: 18 Years and older
Enrollment: 40 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2017 – 2018
U.S. locations: 1
States / cities: New York, New York

Conditions: Saphenous Vein Graft Disease
Interventions: Aspirin, Ticagrelor; Drug
Lead sponsor: Boca Raton Regional Hospital; Other
Eligibility: 18 Years to 90 Years
Enrollment: 250 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2014 – 2021
U.S. locations: 1
States / cities: Boca Raton, Florida

Conditions: HIV Infections
Interventions: Pravastatin, Gemfibrozil, Rosiglitazone; Drug
Lead sponsor: National Institutes of Health Clinical Center (CC); NIH
Eligibility: Not listed
Enrollment: 75 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2002 – 2005
U.S. locations: 1
States / cities: Bethesda, Maryland

Search by objective public record fields.

Carolinas Cardiogenic Shock Initiative

VITALYST Early Feasibility Study in High-Risk PCI Patients (VITALYST EFS)

Aliskiren Effect on Aortic Plaque Progression

Optimal Improvement of Vein Graft Patency Long Term by the Implementation Of Novel Endoscopic Harvesting Techniques

Cardiovascular Outcomes Study of Alogliptin in Patients With Type 2 Diabetes and Acute Coronary Syndrome

Changes in Ischemia and Angina Over 1 Year Among ISCHEMIA Trial Screen Failures With no Obstructive CAD on Coronary CT Angiography

Improving Door-to-Balloon Time in STEMI

Effects of Short Term, High Dose Atorvastatin Therapy on Periprocedural Myonecrosis and Platelet Inhibition After Percutaneous Coronary Intervention (PCI)

A Randomized Evaluation of First-dollar Coverage for Post-MI Secondary Preventive Therapies

Impact of Disclosing Coronary Artery Disease Polygenic Risk Score on Cardiovascular Health

WATCHMAN Left Atrial Appendage System for Embolic PROTECTion in Patients With Atrial Fibrillation

Pharmacy-led Transitions of Care Intervention to Improve Medication Adherence

ACROSS-Cypher Total Occlusion Study of Coronary Arteries 4 Trial

Computed Tomography Coronary Angiogram (CTCA) Versus Traditional Care in Emergency Department Assessment of Potential Acute Coronary Syndromes (ACS)

The Effects of Ranolazine on CPET Parameters in Ischemic Cardiomyopathy Patients (ERIC)

Exploring Sympathetic Nervous System Function in Individuals With Down Syndrome

To Find the Best Dose of pVGI.1(VEGF2) to Benefit Angina Patients When Given With an Experimental Injection Catheter

LV Thrombus Pilot Study for Comparing Enoxaparin Vs. Warfarin

NobleStitch EL STITCH Trial is a PFO Comparative Trial

ACCESS to the Cardiac Cath Lab in Patients Without STEMI Resuscitated From Out-of-hospital VT/VF Cardiac Arrest

VITROS Immunodiagnostic Products hs Troponin I

BVS-OCT Imaging Study

Ticagrelor Antiplatelet Therapy to Reduce Graft Events and Thrombosis

Endothelial Dysfunction as a Risk Factor in HIV Study